Diacerein on Insulin Secretion in Diabetes
Effect of Diacerein on Insulin Secretion in Patients With Type 2 Diabetes Mellitus and Overweight or Obesity
Sponsor: Coordinación de Investigación en Salud, Mexico
Listed as NCT01298882, this PHASE2 trial focuses on Obesity and Overweight and remains completed. Sponsored by Coordinación de Investigación en Salud, Mexico, it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Coordinación de Investigación en Salud, Mexico
- National Council of Science and Technology, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .